Alcyomics Ltd. products

Our human tissue explant assay for the detection and characterisation of adverse immune reactions in vitro. Helping you characterise immune reactions to your novel chemicals, pharmaceuticals, biologicals and cellular therapies.

Assessment of immune activation: Alcyomics has a wide range of cell phenotypic services for your research needs, to benefit both drug discovery and validation. With our in-house state-of-the-art instrumentation, we can analyse and deliver accurate analyses of T-cell proliferation responses and perform multiplex cytokine analysis. This screening test can be used in conjunction with the Skimune® assay to determine adverse immune or allergic reactions to drugs and compounds in both the autologous and allogenic immune settings.

Tissue Engineering 3D Platform Building tissue one layer at a time. Our expertise in the additive manufacturing and 3D printing technology combined with our understanding of 3D tissue models allows us to explore the bioprinting of various cell types (Figure 1) to biofabricate tissue for in-vitro applications. Utilising the speed, precision and selective deposition of drop-on-demand based bioprinting technology, we can arrange cells with geometric complexity that is difficult to achieve with standard tissue culture techniques. To date we have successfully bioprinted primary human skin cells and human MSCs to produce Skimune®3D (Figure 2) and Skimune®OA respectively. Additionally we have been able to demonstrate in-vitro functional applications for both bioprinted tissue constructs.

Disease specific in vitro models for your research. Skimune AD: Our advanced Skimune® model stimulated to demonstrate an AD phenotype through addition of inflammatory cytokines and autologous immune cells.

A new dimension in testing. There is an increasing need to reduce the use of animals for biological testing in both academia and industry. Alcyomics® is at the forefront of 3D model development and validation driving innovation to help meet your research needs.